...
首页> 外文期刊>Journal of Clinical Microbiology >Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.
【24h】

Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.

机译:中枢神经系统结核患者脑脊液单链构象多态性分析检测利福平耐药性。

获取原文
           

摘要

Mutations in a 69-bp region of the rpoB gene of Mycobacterium tuberculosis are associated with rifampin resistance (Rif[r]). These have been detected with mycobacterial DNA extracted from bacterial suspensions or respiratory specimens that were acid-fast smear positive. We experimented with a strategy for the rapid detection of Rif(r) in cerebrospinal fluid (CSF) samples. The strategy involves the amplification of the 69-bp region of rpoB by means of PCR and the identification of nucleotide mutations by single-strand conformation polymorphism (SSCP) analysis of the amplification products. Sixty-five CSF specimens collected from 29 patients (19 patients were coinfected with human immunodeficiency virus) with culture or autopsy-confirmed (22 patients) or highly probable (7 patients) tuberculosis of the central nervous system (CNS-TB) were processed. Amplified products suitable for evaluation by SSCP analysis were obtained from 37 CSF specimens from 25 subjects (86.2%). PCR-SSCP of CSF correctly identified the rifampin susceptibility phenotype of isolates from all 17 patients for whom the results of susceptibility tests carried out with strains cultured from CSF or respiratory samples were available. Moreover, this assay revealed the rifampin susceptibility genotype of isolates from the eight patients (three patients with culture-confirmed CNS-TB and five patients in whom CNS-TB was highly probable) for whom no susceptibility test results were available; the PCR-SSCP data obtained for these patients were concordant with the outcome after a standard antituberculosis treatment. The evolution of a mutation in the rpoB gene was documented in a patient during the course of treatment. PCR-SSCP analysis of CSF seems to be an efficacious method of predicting Rif(r) and would reduce the time required for susceptibility testing from approximately 4 to 8 weeks to a few days.
机译:结核分枝杆菌rpoB基因69 bp区域的突变与利福平耐药(Rif [r])有关。这些是用从抗酸涂片阳性的细菌悬液或呼吸道标本中提取的分枝杆菌DNA检测到的。我们尝试了一种快速检测脑脊液(CSF)样品中Rif(r)的策略。该策略涉及通过PCR扩增rpoB的69 bp区域,并通过扩增产物的单链构象多态性(SSCP)分析鉴定核苷酸突变。从29例患者中收集了65例CSF标本(其中19例患者感染了人类免疫缺陷病毒),并对其进行了培养或尸检确认(22例患者)或极有可能(7例)中枢神经系统结核(CNS-TB)。从25位受试者(86.2%)的37个CSF标本中获得了适合通过SSCP分析评估的扩增产物。 CSF的PCR-SSCP能够正确鉴定所有17例患者的利福平药敏表型,这些患者可使用CSF或呼吸道样品培养的菌株进行药敏试验。此外,该试验还发现了八名患者(没有三名经培养证实的CNS-TB患者和五名中枢神经系统结核病患者)的利福平敏感性基因型,但尚无敏感性测试结果。这些患者获得的PCR-SSCP数据与标准抗结核治疗后的结果一致。在治疗过程中记录了rpoB基因突变的演变。对CSF进行PCR-SSCP分析似乎是预测Rif(r)的有效方法,并将药敏试验所需的时间从大约4到8周减少到几天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号